Angelique Elsa Greco

Title: Angelique Elsa Greco: Innovator in Pharmaceutical Compounds

Introduction

Angelique Elsa Greco is a notable inventor based in Cammeray, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit specific enzymes related to various medical conditions.

Latest Patents

Angelique holds a patent for "Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof." This invention pertains to novel compounds capable of inhibiting certain amine oxidase enzymes. These compounds are particularly useful for treating a variety of conditions, including fibrosis, cancer, and angiogenesis in both human subjects and animals. Additionally, the patent covers pharmaceutical compositions containing these compounds and their various applications.

Career Highlights

Angelique is associated with Syntara Limited, where she continues to advance her research and development efforts. Her work has the potential to impact the treatment of serious health conditions, showcasing her dedication to innovation in the pharmaceutical industry.

Collaborations

Angelique has collaborated with notable colleagues, including Alison Dorothy Findlay and Craig Ivan Turner. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Angelique Elsa Greco is a pioneering inventor whose work in pharmaceutical compounds demonstrates her commitment to improving health outcomes. Her innovative contributions are paving the way for new treatments in various medical fields.